Association of Circulating MicroRNA-142-3p with Graves Disease

Main Article Content

Rashad Ayad Al-Heety
Hayfaa S Al-Hadithi

Abstract

This study aims to investigate the possible role of circulating microRNA-142-3p (miR-142-3p) in the
development of graves disease (GD) and its association with the antibody directed against thyroid
stimulating hormone receptor (TSHR-Ab) production in patients with GD. Forty patients with positive
TSHR-Ab enrolled in this study were divided ,based on treatment, into (22 untreated (newly diagnosed) and
18 treated patients) and based on family history (30 with positive family history and 10 with negative family
history). In addition to forty healthy subjects with sex and age matching as a control group. The expression
level of circulating miR-142-3p was determined by two steps reverse transcription polymerase chain reaction
(RT-PCR) technique. Results show that there is a significant elevation (p < 0.01) in the expression of miR-
142-3p in the serum of both treated and untreated patients compared with controls and in patients with
positive family history compared with negative family history. While its expression is non-significantly
lower (P > 0.05) in the serum of treated patients compared with untreated ones. It has been found that miR-
142-3p expression was positively correlated with levels of TSHR-Ab, FT3, and FT4. In addition, the miR-
142-3p expression has a good diagnostic accuracy with sensitivity (82%) and specificity (80%). In
conclusion, the differential expression of miR-142-3p between patients and healthy controls appears as a
potential biomarker for diagnosis of GD and the positive correlation of miR-142-3p with TSHR-Ab
suggesting the contribution of this miRNA in the development of GD.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Al-Heety RA, Al-Hadithi HS. Association of Circulating MicroRNA-142-3p with Graves Disease. Baghdad Sci.J [Internet]. 2021Dec.1 [cited 2021Dec.4];18(4):1133. Available from: https://bsj.uobaghdad.edu.iq/index.php/BSJ/article/view/4580
Section
article

References

Zheng L, Zhuang C, Wang X, Ming L. Serum miR-

a, miR-155, and miR-210 as potential markers of

Graves’ disease. J Clin Lab Anal. 2018;32(2):e22266.

Gonzalez-Amaro R, Marazuela M. T regulatory

(Treg) and T helper 17 (Th17) lymphocytes in thyroid

autoimmunity. Endocrine. 2016;52(1):30-8.

Lombardi A, Menconi F, Greenberg D, Concepcion

E, Leo M, Rocchi R, et al. Dissecting the genetic

susceptibility to Graves’ disease in a cohort of

patients of Italian origin. Frontiers in endocrinology.

Mar 8;7:21.

Mitchell AL, Pearce SHS. 70 - Autoimmune Thyroid

Diseases. In: Rich RR, Fleisher TA, Shearer WT,

Schroeder HW, Frew AJ, Weyand CM, editors.

Clinical Immunology (Fifth Edition). London:

Content Repository Only!; 2019. p. 947-56.e1.

Kahaly GJ, Bartalena L, Hegedüs L, Leenhardt L,

Poppe K, Pearce SH. 2018 European Thyroid

Association Guideline for the Management of

Graves’ Hyperthyroidism. Eur Thyroid J.

;7(4):167-86.

Hiratsuka I, Yamada H, Munetsuna E, Hashimoto S,

Itoh M. Circulating MicroRNAs in Graves' Disease in

Relation to Clinical Activity. Thyroid.

;26(10):1431-40.

Yau TO, Tang CM, Harriss EK, Dickins B,

Polytarchou C. Faecal microRNAs as a non-invasive

tool in the diagnosis of colonic adenomas and

Open Access Baghdad Science Journal P-ISSN: 2078-8665

, 18(4): 1133-1139 E-ISSN: 2411-7986

colorectal cancer: A meta-analysis. Sci Rep.

;9(1):9491.

Garo LP, Murugaiyan G. Contribution of MicroRNAs

to autoimmune diseases. Cell Mol Life Sci.

;73(10):2041-51.

Panagal M, Biruntha M, Vidhyavathi RM,

Sivagurunathan P, Senthilkumar SR, Sekar D.

Dissecting the role of miR-21 in different types of

stroke. Gene. 2019;681:69-72.

Abdul-Maksoud RS, Sediq AM, Kattaia A, Elsayed

W, Ezzeldin N, Abdel Galil SM, et al. Serum miR-

and miR-155 expression levels as novel

biomarkers for rheumatoid arthritis diagnosis. Br J

Biomed Sci. 2017;74(4):209-13.

Schmittgen TD, Livak KJ. Analyzing real-time PCR

data by the comparative CT method. Nature

Protocols. 2008;3(6):1101-8.

Zhang L, Masetti G, Colucci G, Salvi M, Covelli D,

Eckstein A, et al. Combining micro-RNA and protein

sequencing to detect robust biomarkers for Graves'

disease and orbitopathy. Sci Rep. 2018;8(1):8386.

Allelein S, Diana T, Ehlers M, Kanitz M, Hermsen D,

Schott M, et al. Comparison of a Bridge

Immunoassay with Two Bioassays for Thyrotropin

Receptor Antibody Detection and Differentiation.

Horm Metab Res. 2019;51(6):341-6.

Diana T, Olivo PD, Kahaly GJ. Thyrotropin receptor

blocking antibodies. Horm Metab Res. 2018

Dec;50(12):853-62.

Hesarghatta S A, Abraham P. Measuring TSH

receptor antibody to influence treatment choices in

Graves' disease. J Clin Endocrinol Metab.

;86(5):652-7.

Chen X, Zhou Y, Zhou M, Yin Q, Wang S.

Diagnostic Values of Free Triiodothyronine and Free

Thyroxine and the Ratio of Free Triiodothyronine to

Free Thyroxine in Thyrotoxicosis. Int J Endocrinol.

;2018:4836736.

Chen X, Huang F, Qi Y, Zhou M, Yin Q, Peng Y, et

al. Serum and thyroid tissue level of let-7b and their

correlation with TRAb in Graves’ disease. J Transl

Med. 2018;16(1):188.

Mazzone R, Zwergel C, Artico M, Taurone S, Ralli

M, Greco A, et al. The emerging role of epigenetics

in human autoimmune disorders. Clin Epigenetics.

;11(1):34.

Wang J, Chen J, Sen S. MicroRNA as Biomarkers

and Diagnostics. J Cell Physiol. 2016;231(1):25-30.

Martinez-Hernandez R, Sampedro-Nunez M,

Serrano-Somavilla A, Ramos-Levi AM, de la Fuente

H, Trivino JC, et al. A MicroRNA Signature for

Evaluation of Risk and Severity of Autoimmune

Thyroid Diseases. J Clin Endocrinol Metab.

;103(3):1139-50.

Long H, Wang X, Chen Y, Wang L, Zhao M, Lu Q.

Dysregulation of microRNAs in autoimmune

diseases: Pathogenesis, biomarkers and potential

therapeutic targets. Cancer Lett. 2018;428:90-103.

Esmailzadeh S, Mansoori B, Mohammadi A,

Baradaran B. Regulatory roles of micro-RNAs in T

cell autoimmunity. Immunol Invest. 2017;46(8):864-

Sharma S. Immunomodulation: A definitive role of

microRNA-142. Dev Comp Immunol. 2017;77:150-

Liu Y, Song X, Meng S, Jiang M. Downregulated

expression of miR-142-3p in macrophages

contributes to increased IL-6 levels in aged mice. Mol

Immunol. 2016;80:11-6.

Liu C, Yang H, Shi W, Wang T, Ruan Q.

MicroRNA-mediated regulation of T helper type

/regulatory T-cell balance in autoimmune disease.

Immunol. 2018;155(4):427-34.

Dudics S, Venkatesha SH, Moudgil KD. The Micro-

RNA Expression Profiles of Autoimmune Arthritis

Reveal Novel Biomarkers of the Disease and

Therapeutic Response. Int J Mol Sci. 2018;19(8):

Al-Heety RA, Al-Hadithi HS, Turki KM. Correlation

of circulating miRNA-146a-5p and let-7b expression with thyroid-stimulating hormone receptor antibody

in patients with graves disease. Gene Reports.

;19:100608.

Wang B, Shao X, Song R, Xu D, Zhang JA. The

Emerging Role of Epigenetics in Autoimmune

Thyroid Diseases. Front Immunol. 2017;8:396.

Zhu J, Zhang Y, Zhang W, Zhang W, Fan L, Wang L,

et al. MicroRNA-142-5p contributes to Hashimoto's

thyroiditis by targeting CLDN1. J Transl Med.

;14(1):166.